Terminated NCT00734435
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including National City Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 55 Years
Countries United States
Sponsor Orexigen Therapeutics, Inc
Condition Schizophrenia Withdrawn NCT05179772
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Philadelphia Addiction Drug From 18 Years to 65 Years
Countries United States
Sponsor University of Pennsylvania
Condition Addiction Completed NCT00592930
This summary needs review. Please check the official study record and contact the research team for details.
In New Hyde Park Eating disorders Drug From 12 Years to 23 Years
Countries United States
Sponsor Northwell Health
Condition Eating disorders Completed NCT00260962
This summary needs review. Please check the official study record and contact the research team for details.
In Ottawa Eating disorders Drug Over 18 Years
Countries Canada
Sponsor Ottawa Hospital Research Institute
Condition Eating disorders Completed NCT00320489
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Escondido Schizophrenia Drug From 18 Years to 65 Years
Countries United States, France, Canada, ...
Sponsor Eli Lilly and Company
Condition Schizophrenia Completed NCT00190892
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Everton Park Bipolarity Drug From 18 Years to 65 Years
Countries Australia, Greece, Hungary, ...
Sponsor Eli Lilly and Company
Condition Bipolarity Completed NCT00113594
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Cerritos Bipolarity, Schizophrenia Drug From 13 Years to 17 Years
Countries United States, Russia
Sponsor Eli Lilly and Company
Condition Bipolarity, Schizophrenia Completed NCT00510146
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Beijing Bipolarity, Depression Drug From 18 Years to 64 Years
Countries China, Japan, South Korea
Sponsor Eli Lilly and Company
Condition Bipolarity, Depression Completed NCT00034580
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Berkley Bipolarity Drug From 18 Years to 70 Years
Countries United States
Sponsor Eli Lilly and Company
Condition Bipolarity Completed NCT00485680
This summary needs review. Please check the official study record and contact the research team for details.
In Shanghai Bipolarity Drug Over 18 Years
Countries China
Sponsor Eli Lilly and Company
Condition Bipolarity Completed EUCTR 2004-001482-17
This summary needs review. Please check the official study record and contact the research team for details.
In Lithuania Bipolarity Other
Countries Lithuania
Sponsor Eli Lilly and Company
Condition Bipolarity Completed NCT02287259
This study is completed in Japan. It focuses on depression.
In Chiba Bipolarity, Depression Drug From 18 Years to 65 Years
Countries Japan
Sponsor Tadashi Hasegawa
Condition Bipolarity, Depression